Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup's 3D microscope ...

Alpenglow Biosciences, the leader in clinical-grade 3D digital pathology and AI-powered spatial analytics, and PathNet, one of the nation’s foremost pathology laboratories and largest ...

Gozellix performance for imaging of biochemically recurrent prostate cancer appears to be affected by serum PSA levels and site of disease; for imaging of metastatic pelvic lymph nodes prior to ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Gozellix, a PSMA-PET imaging agent, is FDA-approved for detecting prostate cancer metastasis and recurrence, enhancing access to advanced imaging. The approval is supported by data from the PSMA-PreRP ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought. A new study led by researchers at the UCLA Health ...

LOS ANGELES & RESTON, Va.--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and ...